The General Shareholders Meeting of INVL Baltic Real Estate (hereinafter – the Company) held on 30 April 2025 decided to approve the proposed dividend allocation of EUR 0.09 per share for the year 2024 (the total amount of dividends allocation amounts to EUR 0.716 million). The Company notes that dividends will be paid out and the dividend payment procedure for 2024 will be published within one month of the General Shareholders Meeting that approved the decision to allocate the dividends. Persons, who will ...

INCREASED REVENUES, STRONG PROFITABILITY DESPITE EXCEPTIONAL HIGH TAX IMPACT CRÉDIT AGRICOLE S.A. CRÉDIT AGRICOLE GROUP Q1 2025 Var. Q1/Q1 Q1 2025 Var Q1/Q1 Revenues 7,256 <td style="width:113.54px;;text-align: right ; vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-a ...

Luxembourg, April 30, 2025 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s leading integrated steel and mining company, today announced results1 for the three-month period ended March 31, 2025. 1Q 2025 key highlights: Safety focus: Protecting employee health and well-being remains an overarching priority of the Company. LTIF rate of 0.63x in 1Q 2025. dss+ safety audit recommendations implementation phas ...

First-quarter 2025 financial information Promising start to 2025Electrification segment, a key driver of our growth, delivering +6.8% organic growth in Q1 2025No material impact from “US Liberation Day” Tariff2025 guidance confirmed First-quarter 2025 standard sales of €1,815.4 million, up +4.1% organically year-on-year: Electrification businesses were up +6.8% organically, with double digit organic growth in PWR-Transmission segment. PWR-Grid and PWR-Connect remained well-orientedRecord adjusted backlo ...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – April 30, 2025Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2025. Business highlights Q1 2025 QUVIVIQ™ (daridorexant): Strong performance and accelerating sales in Q1 2025 with total Idorsia-led net sales of CHF 25 m.QUVIVIQ EUCAN: Demand grew by 50% from Q4 2024 to Q1 2025, strongly driven by reimbursed markets. Overall, more than 10 million nights of sleep prescribed in Q1 2025.Daridorexant: Positi ...

Ress Life Investments Nybrogade 12 DK-1203 Copenhagen K Denmark CVR nr. 33593163 www.resslifeinvestments.com To: Nasdaq Copenhagen Date: 30 April 2025 Corporate Announcement 16/2025 Ress Life Investments A/S to divest most of its current life insurance portfolio Ress Life Investments A/S (RLI) has entered into an agreement whereby RLI will sell its life insurance portfolio to a market counterparty at a price corresponding to the Net Asset Value (NAV) of the portfolio. The objective of the transaction is t ...

Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - April 30th, 2025, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: https://www.melexis.com/en/news/2025/financial/melexis-q1-2025-results Attachment PR_ENG_Melexis_Q1 2025 ...

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Q1 2025 net sales of USD 2,480 million up by 3% in constant currencies (cc); stable in USDup by 5%[1] at a comparable growth rate (CGR), when adjusted for impact of 2024 acquisition of US biosimilar Cimerli® (ranibizumab) and 2024 divestment of China businessten largest-selling medicines grew by combined 4% and represented 33% of net sales Europe net sales grew by 7%[1]. International declined by 2%[1] and increased by 2 ...

Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), April 30, 2025 dsm-firmenich Q1 2025 trading update Management Report Q1 2025 highlights Good start to the year with strong organic sales and earnings growthProgressing well on 2025 strategic planSale of Feed Enzymes business for €1.5 billion announcedAnimal Nutrition & Health exit process advancing as planned€1 billion share buyback program commenced in AprilFY 2025 outlook unchanged: Adjusted EBITDA at least €2.4 billion Key figures in € ...

Regulated information Revenue of €451 million, 2.8% lower LFL, with soft market demand partly offset by mix improvement in Europe and double-digit volume growth in North America;Adj. EBITDA margin resilient at 11.2%, with strong delivery of the cost transformation program ;Divestment of Brazilian business successfully concluded;Long-term financing secured, with new €400 million bond maturing in 2030;Full year outlook confirmed, with volume gains in H2 as main driver. CEO quote Gustavo Calvo Paz, Ontex’s C ...